Biologics Development x185


Biologics Development: A Regulatory Overview 2004

- $145.00

View the Table of Contents 

Written by more than a dozen FDA officials and industry experts, Biologics Development: A Regulatory Overview (2004) is the first text to analyze the FDA’s regulation of biotech/biologic products following the agency’s historic transfer of therapeutic biological products to the Center for Drug Evaluation and Research (CDER). Written by CDER and BER officials and industry experts, this reference offers an expansive examination of the FDA’s regulatory of biologic products.

In its third edition, this comprehensive text has become the world’s most widely read resource on the FDA’s regulation, review, and approval of therapeutic biologics, vaccines, gene/cellular therapies, and other biotech products. The expanded 2004 edition is the first book to fully characterize the new dual-center regulatory system for biological products following the FDA’s stunning reassignment of biological products in late 2003. From preclinical testing to post-marketing regulatory requirements and from biological manufacturing to electronic IND/BLA submissions, this text addresses every aspect of the new era of biological/biotech product development and regulation.

Reader Testimonials:

“Authored by FDA and industry officials, Biologics Development: A Regulatory Overview is the first text to provide a detailed analysis of the FDA’s regulation of the development process for… biological products. [It] gives special emphasis to the recent wave of organizational, management, and operating initiatives within… CBER… including lot release, user fees, and promotional labeling policies.” 
RAPS News (on the First Edition)

“A first-rate information source on the biologics approval process! This text provides an up-to-date reference for the expert, and an excellent overview for the novice. More important, it is one of the precious few sources for obtaining the detailed thoughts of current CBER officials.”
Gary E. Gamerman, M.S., J.D., Fenwick & West (on the First Edition)


LinkedIn twitter Facebook 

On-Demand GCP Refresher Training 

Too busy to attend a course? Our newly-released GCP eLearning course may be your solution!
For details on our scenario-based practical GCP application on-demand course, click here.

GCP for Investigators

Barnett’s scenario-based eLearning course is designed with the busy Principal Investigator in mind.  Based on real-life scenarios encountered by investigative site teams, this highly focused 7-module GCP training is designed to ensure comprehensive understanding of the key components of GCP.

For more details on this scenario-based eGCP program for investigators please click here. 

BARNETT CATALOG The Barnett Catalogue is your comprehensive guide to the myriad live, web, and custom training opportunities offered throughout the year. 

Jan - July 2014 Edition

Winter CatalogDownload Today!  

Blended Curriculum Path for the CRA, CRC, and Project Manager

BCP Cover

Download Today! 






 View Catalog of Offerings   

New Titles added every month! 
Course Alumni Save 50% 


Monitoring Clinical Drug Studies: Intermediate 

Informed Consent Content & Process Requirements for Biobanking Studies 

Auditing Techniques for Clinical Research Professionals 


10-Week CRA & CRC Beginner Program  

Trial Master File (TMF) for Sponsors: Set-Up and Maintenance 

Use of Notes to File in Clinical Trial Essential Documentation 

10-Week Clinical Research Associate (CRA) On-Boarding Program  


2012 GCP Question & Answer Guide Print Edition 

2012 Good Clinical Practice Question & Answer Guide Electronic Edition 

CFR/ICH GCP Reference Guide 2012 (Spiral Bound) 

CFR/ICH GCP Reference Guide 2012 (Perfect Bound) 

PAREXEL's Bio/Pharma R&D Statistical Sourcebook 2012/2013 (Hard Copy)